DiagnaMed Holdings Corp. (TSE:DMED) has released an update.
DiagnaMed Holdings Corp. has introduced CERVAI™, an innovative AI-driven brain health assessment tool, at the University of Miami Comprehensive Center for Brain Health. The technology aims to predict Alzheimer’s disease and other neurological conditions by evaluating a person’s brain resilience and performance. It has been clinically validated and shows a high accuracy rate in identifying cognitive impairment in a recent study.
For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.
